To develop and apply innovative technologies in order to reveal the mechanobiological signalling networks in cartilage and joint disorders and provide strategies for repair.
To be a world-class research programme providing innovative technologies for – and insight into – pathology, diagnosis and treatment of cartilage and musculoskeletal joint disorders.
The ICR Group will enable commercial potential from translation of research into Medtech patents and spinoffs, strengthen the University’s research capacity in mechanobiology, and benefit global health and well-being.
The Integrative Cartilage Research Group values high-quality research results based in our solid expertise, and performed in cooperation with our partners (industry, clinic, government, academic, non-profit). Our team is characterised by a practical, resourceful and innovative approach to Biomedical Engineering problems.